Disc Medicine, Inc. (IRON) is in Healthcare, Biotechnology, based in United States, listed on NasdaqGM. Market cap 2.33B USD. 52-week range 40.00 to 99.50 USD. Data as of 2026-10-09.
Disc Medicine, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases in the United States. The company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, primarily heme biosynthesis and iron ...